Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Non-small Cell Lung Cancer Metastatic × Platinum × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 32 Lung Neoplasms 18 Squamous Cell Carcinoma of Head and Neck 17 Uterine Cervical Neoplasms 16 Small Cell Lung Carcinoma 16 Ovarian Neoplasms 12 Oropharyngeal Neoplasms 10 Urinary Bladder Neoplasms 9 Fallopian Tube Neoplasms 9 Carcinoma 9 Stomach Neoplasms 8 Mouth Neoplasms 8 Laryngeal Neoplasms 8 Hypopharyngeal Neoplasms 8 Breast Neoplasms 7 Nasopharyngeal Carcinoma 6 Mesothelioma, Malignant 6 Adenocarcinoma of Lung 6 Triple Negative Breast Neoplasms 5 Pancreatic Neoplasms 5 Medulloblastoma 5 Cholangiocarcinoma 5 Prostatic Neoplasms 4 Neuroblastoma 4 Ganglioneuroblastoma 4 Gallbladder Neoplasms 4 Esophageal Neoplasms 4 Brain Neoplasms 4 Vulvar Neoplasms 3 Urethral Neoplasms 3

Interventions

pembrolizumab 3 Bevacizumab 3 tusamitamab ravtansine 2 Ramucirumab 2 Pemetrexed 2 Gemcitabine 2 Erlotinib Hydrochloride 2 Docetaxel 2 Carboplatin 2 1-(1-(imidazo(1,2-a)pyridin-6-yl)ethyl)-6-(1-methyl-1H-pyrazol-4-yl)-1H-(1,2,3)triazolo(4,5-b)pyrazine 2 vistusertib 1 vandetanib 1 telomerase reverse transcriptase p572Y, human 1 spartalizumab 1 sotorasib 1 olaparib 1 necitumumab 1 icotinib 1 durvalumab 1 dacomitinib 1 capivasertib 1 aumolertinib 1 Vinorelbine 1 Radiosurgery 1 Platinum 1 Paclitaxel 1 MLN 8237 1 LY3023414 1 Injections 1 GC Temporary Stopping 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05407155 2022-06-07

BETTER

Fudan University

Phase NA Unknown

Non-small Cell Lung Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡